Iguratimod is an organic molecular entity being investigated for use in rheumatoid arthritis. It functions as an immunosuppressive agent and is supplied as an active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 123663-49-0
Piperacillin/tazobactam
pharmaceutical raw material
Topotecan
pharmaceutical raw material
Ixazomib citrate
pharmaceutical raw material
Mecetronium bromide
pharmaceutical raw material
N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide
ANMATWQYLIFGOK-UHFFFAOYSA-N
CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3